A review on post-puberty hypothyroidism: A glance at myxedema

Pakistan Journal of Biological Sciences

Volumn 13, Issue 18, 2010, Pages 866-876

  Mansourian, A R ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypothermia; Hypothyroidism; Myxedema comma; Thyroid stimulating hormone; Thyroxin

Indexed keywords

EID: 77957560325     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2010.866.876     Document Type: Article

References (120)

1. Abrams, J.J. and S.M. Grundy, 1981. Cholestetol metabolism in hypothyroidism and hyperthyroidism in man. J. Lipid Res., 22: 323-338.
2. Adriaanse, R., G. Brabant, E. Endert and W.M. Wiersinga, 1993. Pulsatile TSH release in patients with untreated pituitary disease. J. Clin. Endocrinol. Metab., 77: 205-209.
3. Althaus, B.U., J.J. Staub, A.L. Ryff-DeLeche, A. Oberhansli and H. Stahelme, 1998. B.LDL/HDL changes in subclinical hypothyroidism: Possiblerisk factors for coronary heart disease. Clin. Endocrinol., 28: 157-163.
4. Arafah, B.M., 1986. Reversible hypopitutatism in patients with large non-functioning pitulitary adenomas. J. Clin. Endocrinol. Metab., 62: 1173-1179.
5. Arafah, B.M., 1994. Decreased levothyroxine requirement in women with hypothyriodism during androgen therapy for breast cancer. Ann. Int. Med., 121: 247-251.
6. Bakker, S.J.L., J.C. Maaten, C. Popp-Snijders, J.P.J. Slaets, R.J. Heine and R.O.B. Gans, 2001. The relationship between thyrotropin and low density lipoprotein cholesterole is modified by insulin sensitivity in healthy euthyroid subjects. J. Clin. Endocrinol. Metab., 86: 1206-1211.
7. Bastenie, P.A., L. Vanhaelst, J. Goldstein and P. Smets, 1977. Asymptomatic autoimmune thyroiditis and coronary heart disease. Cross-sectional and prospective studies. Lancet, 23: 155-158.
8. Bastenie, P.A., L. Vanhaelst, M. Bonnyns, P. Neve and M. Staquet, 1971. Preclinical hypothyroidism: A risk factor for coronary heart disease. Lancet, 30: 203-204.
9. Bell, G.M., W.T. Todd, J.C. Forfar, C. Martyn and C.G. Wathen et al., 1985. End-organ responses to thyroine therapy in subclinical hypothyroidism. Clin. Endocrinol., 22: 83-89.
10. Berens, S.C., R.S. Bernstein, J. Robbins and K. Wolf, 1970. Antithyroid effects of lithium. J. Clin. Invest, 49: 1357-1367.
11. Bigos, S.T., E.C. Ridgway, LA. Kourides and F. Maloof, 1978. Spectrum of pituitary alter-ations with mild and severe thyroid impairment. J. Clin. Endocrinol. Metab., 46: 317-325.
12. Biondi, B. and D.S. Cooper, 2008. The clinical significance of sub clinical thyroid dysfunction. Endocr. Rev., 29: 76-131.
13. Bonger, U., H.R. Arntz, H. Peters and H. Schleusener, 1993. Subclinical hypothyroidism and hyperlipidemia: Indiscriminate 206 thyroxine treatment not justified. Acta Endocrinol., 28: 202-206.
14. Bough, E.W., W.F. Crowley, C. Ridgway, H. Walker, F. Maloof, G.S. Myers and G.H. Daniels, 1978. Myocardial function in hypothyroidism. Relation to disease severity and response to treatment. Arch. Int. Med., 138: 1476-1480.
15. Brabant, G., E. Dogu, H. Kausche, K. Pank and A. Von zur Muhlen et al., 1994. Temporal pattern of TSH secretion and its significance in evaluating thyroid status from single TSH determinations. Exp. Clin Endocrinol, 66: 280-284.
16. Brauman, H. and K. Corvilain, 1968. Growth hormone respons to hypoghycemia in myxedema. J. Clin. Endocrinol. Metab., 28: 301-305.
17. Braverman, K.E., K.A. Woeber and S.H. Ingbar, 1969. Induction of myxedema by iodide in patients euthtroid after radioiodine or surgical treatment of diffuse toxic goiter. N. Engl. J. Med., 281: 816-821.
18. Braverman, L.E., S.H. Ingbar, A.G. Vagenakis, L. Adams and F. Maloof, 1971. Enhabced susceptibility to iodide myxedema in patients with Hashimatos thyroiditis. J. Clin. Endocrinol., 32: 515-521.
19. Braverman, L.E., 1994. Iodine and the thyroid: 33 years of study. Thyroid, 4: 351-356.
20. Browning, M.C., W.M. Bennet, A.J. Kirkaldy and R.T. Jung, 1988. Intra-individual variatio of thyroxine, triiodothyronin and thyrotropin in treated hypothyroid ptients: Implications for monitoring replacement therapy. Clin. Chem., 34: 696-699.
21. Caron, P., C. Calazel, H.J. Parra, M. Hoff and J.P. Louvet, 1990. Decreased HDL cholesterol in subclinical hypothyroidism: The effortof L-thyroxine therapy. Clin Endocrinol, 33: 519-523.
22. Chau, A.M., M.J.G. Lunch and J.D. Bailey et al, 1970. Hypothyroidism in cystinosis: A clinical endoctino logic and histologic study involving sixteen patients with cytinosis. Am. J. Med., 48: 678-683.
23. Constine, K.S., P.D. Woolf, D. Cann, G. Mick, K. McCormick, R.F. Raubertas and P. Rubin, 1993. Hypothalamic-pitutaty dus function atter radiation for brain tumors. N. Engl. J. Med., 328: 87-94.
24. Contempre, B., J.E. Dumont, N. Bebe, C.H. Thilly, A.T. Diplock and J. Vanderpas, 1991. Effect of selenium supplementation in hypothyroid subjects of an Iodine and selenium deficient area: The possible danger of indiscriminate supplementation of oidine-deficient subjects with seleniyum. J. Clin. Endocrinol. Metab., 73: 213-215.
25. Copper, D.S., R. Alpern and L.C. Wood 1984. L-Thyroxine therapy in subclinicak hypothyroidism. A double-blind, placebo-controlled trial. Ann. Int. Med., 101: 18-24.
26. Cnspell, K.R., W. Parson and G. Hokkifield, 1965. A study of the rate of protein synthesis before and during the administration of L-Triodothyronin to patients with myxedema and healthy volunteers using N-15 glycine. J. Clin. Invest., 35: 164-167.
27. Cunningham, J.J. and U.S. Barzel, 1984. Lean body mass is a predictor of the daily requirement of thyroid hormone in older men and women. J. Am. Geratr. Soc, 32: 204-207.
28. Curran, P.G. and L.J. DeGroot, 1991. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr. Rev., 12: 135-150.
29. DeLuca, F., T. Arrigo, E. Pandullo, M.F. Siracusano, S. Benvenga and F. Trimarchi, 1986. Changes in thyroid function tests induced by 2 month carbamazepine treatment in L-thyroxine-substituted hypothyroid children. Eur. J. Pediatr., 145: 77-79.
30. Diekman, M.J., J.A. Romin, E. Endetrt and H.W. Sauerewein, 1988. Thyroid hormones modulated serum leptin levels: Observations in thyrotoxic and hypothyroid women. Thyroid, 8: 1081-1086.
31. Dillann, W., 1983. Thyroid hormone and heart. Thyroid Today, 6: 1-6.
32. Dong, B.J., E.E. Hauck, J.C. Ganbetoglio, L. Gee, J.R. White, J.L. Bubp and F.S. Greenspan, 1997. Bioeqivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA., 227: 1205-1213.
33. Dos Remedios, L. V., P.M. Weber, R. Feldman, D. A. Schurr and T.G. Tsoi, 1980. Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch. Intern. Med., 140: 1045-1049.
34. Edwards, O.M. and J.D. Clark, 1986. Post-traumatic hypopituitarism. Six cases and a review of the literature. Medicine, 65: 281-290.
35. Evered, D.C., B.J. Ormston, P. Smith, R. Hall and D.T. Bird, 1973. Grades of hypothyroidism. Br. Med. J., 1: 657-662.
36. Faber, J., LB. Lumhotz, C. Kirkegaard, S. Poulsen, P.H. Jorgensen, K. Siersbaek-Nielsen and T. Friis, 1985. The effects of phenytion (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3- triiodothyronine and 3,5- diiodothyronine in man. J. Clin Endocrinol. Metab., 61: 1093-1099.
37. Fazio, S., E.A. Palmieri, G. Lombardi and B. Biondi, 2004. Effect of thyroid hormone on the cardiovascular system. Recent Prog. Horm. Res., 59: 31-50.
38. Fish, L.H., H.L. Schwartz, J. Cavanaugh, M.W. Steffes, J.P. Bantle and J.H. Oppenheimer, 1987. Replacement does, metabolism and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothronine in pituitary feedback in humans. N. Engl. J. Med., 316: 764-770.
39. Fliers, E. and W.M. Wiersinga, 2003. Myxdema coma. Rev. Endocr. Metab. Dis., 4: 137-141.
40. Ford, H.C. and J.M. Carter, 1990. Haemostasis in hypothyroidism. Postgrad Med. J., 66: 280-284.
41. Forfar, J.C, C.G. Watken, W.T. Todd, G.M. Bell, W.J. Hannan, A.L. Muir and A.D. Toft, 1985. Left wentriculer perfomance in subclinical hypothyroidism. Q. J. Med., 37: 857-865.
42. Gaitan, E., R.C. Coosey and K. Legan, 1993. Antiyroid and goitogenic effects of coat- water extracts from iodine-sufficient goiter areas. Thyroid, 63: 49-53.
43. Geul, K.W., I.L. van Sluisveld, D.E. Grobbee, R. Docter and A.M. de Bruyn et at, 1993. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: Associations with serum lipids. Clin. Endoorinol., 39: 275-280.
44. Gordin, A. and B.A. Lamberg, 1981. Spontaneous hypothyroidism in symptomless thyroiditis. A longterm follow-up study. Clin. Endocrinol., 15: 537-543.
45. Griffin, J.E., 1990. Hypothyroidism in the elderly. Am. J. Med. Sci., 299: 334-345.
46. Gull, W.W., 1874. On a cretinioid state supervening in adult life in woman. Trans. Clin. Soc, London, 7: 180-189.
47. Hak, A.E., H.A.P. Pols, H.A. Drexhage and J.CM. Witteman, 2000. Subclinical hypothyrodism is an independent risk factor atherosclerosis and myocardial infarction in elderly women: The Rotterdam study. Ann. Int. Med., 132: 270-278.
48. Hall R. and M.F. Scanlon, 1979. Hypothyroidism: Clinical features and complications. Clin. Endocrinol. Metabol., 8: 29-38.
49. Hayashi, Y., H. Tamai and S. Fukata, 1985. A long-term clinical immunological and histological follow-up study of patients with goiteious chronic lymphocytic thyroiditis. J. Clin. Endocrinol. Metab., 61: 1172-1178.
50. Hays, M.T., 1988. Thyroid hormone and the gut. Endocr. Res., 14: 203-224.
51. Hays, M.T., 1991. Localization of human thyroxine absorption. Thyroid, 1: 241-248.
52. Hecht, A. and H. Gershberg, 1968. Diabetes mellitus and primary hypothyroidism. Metabolism, 17: 108-108.
53. Ishii, H., M. Inada and K. Tanaka, 1983. Induction of outer and inner ring monodero-dinases in human thyroid gland by thyrotropin. J. Clin. Endocrinol. Metab., 57: 500-505.
54. Isley, W.L., 1990. Effect of rifampin therapy on thyroid function tests in hypoty- hormone in patients receiving levothyroxine for primary hypothyroidism. Ann. Int. Med., 113: 553-555.
55. Jordan, R.M., 1995. Myxedema coma. Pathophysilogy, therapy and facrors affecting prognosis. Med. Clin. North Am., 79: 185-194.
56. Kritchevsky, D., 1960. Influence of thyroid hormones and related compounds on cholesterol biosynthesis and degradation: A review. Metabolism, 9: 984-994.
57. Kurland, G.S., J.L. Kucas and A.S. Freedberg, 1961. The metabolism of intravenously in- fused 14C-labeled cholesterol in euthyiroidism and myxedema. J. Lab. Clin Med., 57: 574-579.
58. Ladenson, P.W., A. Levin, E.C. Ridgway and G.H. Daniels, 1984. Complications of surgery in hypothyroid patients. Am. J. Med., 77: 261-266.
59. Lanberg, B.A. and R. Grabeck, 1955. The serum protein pattern in disorder of thyroid function. Acta Endocrinol., 19: 91-100.
60. Langer, P., M. Tajtakova, G. Fodor, A. Kocan, P. Bohov, J. Michalek and A. Kreze, 1998. Increased thyroid volume and prevalence of thyroid disorders in an area heavily polluted by polychlorinated biphenyls. Eur. J. Endocrinol, 139: 402-409.
61. Larsen, P.R, 1982. Thyroid pituitary infraction: Feedback regulation of thyrotropin secretion by thyroid hormon. N. Engl. J. Med., 306: 23-32.
62. Laurberg, P., 1984. Mechanisms governing the relative proportions of thyroxine and3,5,3-triiodothyronine in thyroid secretion. Metabolism, 33: 379-392.
63. Lawrence, A.M., J.F. Wilbure and T.C. Hagen, 1973. The pituitary and primary hypothyroidism: Enlarment and unusual growth hormone growth secretory responses. Arch Intern. Med., 132: 327-333.
64. Lewallen, C.G., J.E. Rail and M. Berman, 1959. Studies of iodoalbumib metabolism. II. The effects of thyroid hormone. J. Clin Invest, 38: 88-88.
65. Lum, S.M., J.T. Nicoloff, C.A. Spencer and E.M. Kaptein, 1984. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J. Clin. Invest., 73: 570-575.
66. Mansourian, A.R., E.O. Ghaemi, A. Ahmadi, A. Saifi, A.V. Moradi and S. Bakhshandehnosrat, 2007. A survy of urinary iodine concentration in South East of Caspian Sea in Northern Iran. Pak. J. Biol. Sci., 10: 2166-2171.
67. Mansourian, A.R., E. Ghaemi, A.R. Ahmadi, A. Marjani, A. Saifi and S. Bakhshandehnosrat, 2008. Serum lipid level alteration in sub clinical hypothyroid patients in Gorgan (South east Caspian Sea), L. Chinese Clin. Med., 3: 206-210.
68. Mannisto, M., M. Vaarasmaki, A. Pouta, A.L. Hartikainen and A. Ruokonen et al., 2010a. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J. Clin. Endocrinol. Metab., 95: 1084-1094.
69. Mansourian, A.R., 2010b. The immune system which adversely alter thyroid functions: A review on the concept of autoimmunity. Pak. J. Biol. Sci.,
70. Mansourian, A.R., 2010c. The state of lipid profiles in sub clinical hypothyroidism: A review of Literature. Pak. J. Biol. Sci., 13: 556-562.
71. Mansourian, A.R., 2010. Thyroid function tests during first-trimester of pregnancy: A review of literature. Pak. J. Biol. Sci., 13: 664-673.
72. Mansourian, A.R., A.R. Ahmadi, H.R. Mansourian, A. Saifi, A. Marjani, G.R Veghari and E. Ghaemi, 2010. Maternal thyroid stimulating hormone level during the first trimester of pregnancy at the South-East of the Caspian sea in IRAN. J. Clin. Diagnostic Res., 4: 2472-2477.
73. Marjani, A., A.R. Mansourian, E.O. Ghaemi, A. Ahmadi and V. Khori, 2008. Lipid peroxidation in the serum of hypothyroid patients (In Gorgan-South East of Caspian Sea). Asian J. Cell Biol, 3: 47-50.
74. Markou, K., N. Georgopoulos, V. Kyriazopoulous and A.G. Vagenakis, 2001. Iodine-induced hypothyroidism. Thyroid, 11: 501-510.
75. Martino, E., M. Safran, F. Aghini-Lombardi, R. Rajatanavin and M. Lenziardi et al., 1984. Environmental iodine intake and thyroid dysfunstion du ring chronic amiodarone therapy. Ann. Int. Med., 101: 28-34.
76. Martino, E., L. Bartalena and A. Pinchera, 2000. Central Hypothyroidism. In: The Thyroid: A Fundamental and Clinical Text, Braverman, M. and R.D. Utiger (Eds.). 8th Edn, Williams & Wilkins, Philadelphia, pp: 762-773.
77. Mintzer, M.J., 1992. Hypothyroidism and hypothyroidism in elderly. J. Fla. Med. Assoc., 79: 231-235.
78. Monzani, F., N. Caraccio, G. Siciliano, L. Manca, L. Murri and E. Ferrannini, 1997. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J. Clin. Endocrinol. Metab., 82: 3315-3318.
79. Muller, B., D.A. Tsakrns, C.B. Roth, M. Gughelmetti, J.J. Staub and G.A. Marbet, 2001. Haemostatic profile in hypothyroidism as potential risk factor forvascular thrombotic disese. Eur. J. Clin. Invest., 31: 131-137.
80. Nicoloff, J.T. and J.S. LoPresti, 1993. Myxedema coma. A form of decompensate hypothyroidism. Endocronol. Metab. Clin. North Am., 22: 279-290.
81. Nilsson, G., S. Nordlanders and K. Levin, 1976. Studies on subclinical hypothyroidism with special reference to the serum lipid pattern. Acta Med. Scand., 200: 63-76.
82. Nystrom, E., C. Bengtsson and O. Lindquist et al., 1981. Thyroid disease and high concentration of serum thyrotropin in a population sample of women. Acta Med. Scand., 210: 39-46.
83. Nystrom, E., K. Caidahl, G. Fager, C. Wikkelso, P. A. Lundberg and G. Lindstedt, 1988. A double-bind cross-over 12- month study of L-thyroxine treatment of women with subclinical hypothroidism. Clin. Endocrinol., 29: 63-75.
84. Obuobic, K., J. Smith, L.M. Evans, R. John, J.S. Davies and J.H. Lazarus, 2002. Increased central arterial stiffness in hypothyroidism. J. Clin. Endocrinol. Metab., 87: 4662-4666.
85. Okamura, K., K. Ueda, H. S one, H. Ikenoue and Y. Hasuo et at, 1989. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J. Am. Geriatr. Soc, 37: 317-322.
86. Oliveria, G., M.C. Alnaraz and F. Soriguer et al, 1997. Alteted biovalability due to changes in the fromulation of a commerica peroparation of levothyroxine in patients with differentiated carcinoma. Clin. Endocrinol., 46: 707-711.
87. Oliveira, J.H.A., L. Persani, P. Beck-Peccoz and J. Abucham, 2001. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehans syndrome: Characterization of TSH carbohydrate content and bioactivity. J. Clin. Endocrinol. Metab., 86: 1694-1699.
88. Ooi, T.C., R.M. Whitlock and P.A. Frengley et al, 1980. Systolic time inmtervals and ankle reflex time in patients with minimak TSH elevation: Response to triiodothyronine therapy. Clin. Endpcrinol., 3: 621-627.
89. Ord, W.M., 1978. On myxedema, a term proposed to be applied to an essential condition in the cretinoid affection occasionally observed in middle-aged women. Medico-Chir. Trans., 61: 57-78.
90. Parle, J.V., J.A. Franklyn, K.W. Cross, S.C. Jones and M.C. Sheppard, 1991. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin. Endocrinol. (Oxf), 34: 77-83.
91. Parle, J.V., J.A. Franklyn, K.W. Cross, S.R. Jones and M.C. Sheppard, 1992. Circulating lipids and minor abnormalities of thyroid function. Clin. Endocrinol., 37: 411-414.
92. Persani, L., E. Fenetti, S. Borgato, G. Faglia and P. Beck-Peccoz, 2000. Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J. Clin Endocrinol. Metab., 85: 3631-3635.
93. Praving, H.H., J.M. Hansen, S.L. Nielsen, N. Rossing, O. Munck and N.A. Lassen, 1979. Mechanism of edemaformation in myxedema-increased protein extravasation and relatively slow lymphatic drainage. N. Engl. J. Med., 301: 460-465.
94. Rose, S.R., 2001. Cranial irradiation and central hypopituturism. Trends Endocrinol. Metab., 12: 97-104.
95. Rosenbaum, R.L. and U.S. Brazel, 1982. Levothyroxine replacement dose for primaty hypothyroidism decreases with age. Ann. Int. Med., 96: 53-55.
96. Samuels, M.H., K. Lillehei, B.K. Kleinschmidt-Demasterk, J. Stears and E.C. Ridgway, 1990. Patterns of pul-satil glycoprotein secretion in central hypothyroidism and hypogonadism. J. Clin. Endocrinol. Matab., 70: 391-395.
97. Sawin, C.T., W.P. Castelli, J.M. Hershman, P. McNamara and P. Bacharach, 1985. The aging thyroid: Thyroid defi-ciency in the framingham dtudy. Arch Int. Med., 145: 1386-1388.
98. Shah, J.H. and G.M. Cerchio, 1973. Hypoinsulinemia of hypothroidism. Arch. Int. Med., 132: 657-661.
99. Shah, J.H., G.S. Motto, E. Papagiannes and G.A. William, 1975. Insulin metabolism in hypothyroidism. Diabets, 24: 922-925.
100. Shahmohammadi, F., A.R. Mansourian and H.R Mansourian, 2008. Serum thyroidhormon level in women withnausea and vomiting in early pregnancy. J. Med. Sci., 8: 507-510.
101. Shimon, I., O. Cohen, A. Lubestky and D. Olchovsky, 2002. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyrodidsm. Thyriod, 12: 823-827.
102. Smith, T.J., A.L. Horwitz and S. Refetoff, 1981. The effect of thyroid hormone on g lycos aminogly can accumulation in human skin fibroblasts. Endocrinology, 108: 2397-2399.
103. Smith, T.J., Y. Murata, A.L. Horwitx, L. Philipson and S. Refetoff, 1982. Regulation of glycosaminologlycan synthesis bythyroid hormone in vitro. J. Clin. Invest., 70: 1066-1073.
104. Snyder, P.L., B.F. Fowbe, N.I. Schatz, P.J. Savino and T.A. Gennarelli, 1986. Hypopituitarism following radiation therapy of pituitary adenomas. Am. J. Med., 81: 457-462.
105. Spencer, C.A., J.S. LoPresti and A. Patel et al., 1990. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J. Clin. Endocrinol. Metab., 70: 453-460.
106. Staub, J.J., B.U. Althjaus, H. Engler, A.S. Ryff and P. Trabucco et al., 1992. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin and thyroid reserve and metabolic impact on peripheral target tissues. Am. J. Med., 92: 631-642.
107. Sundbeck, G., P. A. Lundberg, G. Lindstedt, R. Jagenburg and S. Eden, 1991. Incidence and prevalence of thyroid disease in elderly in elderly women: Results from the longitudinal population study of elderly people in Gothenburg, Sweden. Age Ageing, 20: 291-298.
108. Trip, M.D., W.M. Wiersinga and T.A. Plomp, 1991. Incidence, predictability and pathogen-esis of amiodarone- induced thyrotoxicosis and hypothyroidism. Am. J. Med., 91: 507-511.
109. Tsitouras, P.D., 1995. Myxedema comma. Clin. Geriatr. Med., 77: 751-754.
110. Tunbndge, W.M., D.C. Evered, R. Hall, D. Appleton and M. Brewis et al., 1977a. Lipid profiles and cardiovascular disease in the Whickham area with particuler reference to thyroid failure. Clin. Endocrinol., 7: 495-508.
111. Tunbndge, W.M., D.C. Evered, R. Hall, D. Appleton and M. Brewis et al., 1977b. The spectrum of thyroid disease in a community: The Whicham survey. Clin. Endocrinol., 7: 481-493.
112. Vanderpump, M.P., W.M. Tunbridge, J.M. French, D. Appleton and D. Bates et al., 1995. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham survey. Clin. Endocrinol. (Oxf), 43: 55-58.
113. Vanderpuma, M.P., W.M. Tunbridge, J.M. French, D. Appleton and D. Bates et al, 1996. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Theroid, 6: 155-160.
114. Volpe, R., 1977. The roleof autoimmunity in hypoendocrine and hyperendocrine function with special emphasis on autoimmune thyroid disease. Ann. Intern. Med., 87: 86-99.
115. Watanakunakorn, C, R.E. Hodges and T.C. Evans, 1965. Myxedema: A study of 400 cases. Arch Intern. Med., 116: 183-190.
116. Wennlund, A., 1986. Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy. Acta Endocrinol., 113: 47-49.
117. Wiersinga, W.M., 2004. Adult Hypothyroidism and Myxedema Coma. In: Endocrinology, L.J. DeGroot and J.L. Jameson (Eds.). 5th Edn, WB Saunders Co., Philadelphia, pp: 107.
118. Wiersinga, W.M., J.L. Touber, M.D. Trip and E.A. van Royen, 1986. Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-inducedhypothyroidism. J. Clin. Endocrinol. Metab., 63: 485-491.
119. Yamamoto, T., J. Fukuyama and A. Fujiyoshi, 1999. Factors associated with mortality of myxedema coma: Report of eight cases and litetature survey. Thyroid, 9: 1167-1174.
120. Zulewski, H., B. Muller, P. Exer, A.R. Miserez and J.J. Staub, 1997. Estimation of tissue hypothyroidism by a new clinical score: Evaluation of patients with various grades of hypothyroidism and controls. J. Clin Endocrinol. Metab., 82: 771-776.